庆大霉素抗生素暴露与大肠杆菌的关系:体外对庆大霉素耐药的大肠杆菌与大肠杆菌ESBL

D. Kusumawati
{"title":"庆大霉素抗生素暴露与大肠杆菌的关系:体外对庆大霉素耐药的大肠杆菌与大肠杆菌ESBL","authors":"D. Kusumawati","doi":"10.33086/iimj.v3i1.2138","DOIUrl":null,"url":null,"abstract":"Background: The development of bacteria that have been resistant to antibiotics can complicate the treatment process. Either causes of antibiotic resistance is inappropriate use of antibiotics. Gentamycin is an aminoglycoside-derived antibiotic which its role is very significant for gram-negative bacteria. Repeated use of gentamycin antibiotics can cause changes the effectiveness of gentamycin so that non ESBL-Gentamycin susceptible Escherichia Coli will change into ESBL-Gentamycin resistant Escherichia coli. Objective: This study aims to prove that repeated exposure to Gentamycin in vitro will change non ESBL-Gentamycin susceptible Escherichia Coli into ESBL Gentamycin resistant Escherichia Coli. Methods: This was an experimental study with 30 samples of non ESBL-Gentamycin susceptible Escherichia coli isolates identified from the Phoenix. Non ESBL- Gentamycin susceptible Escherichia coli was tested by giving exposure to Gentamycin for 14 days, then ESBL screening was tested by Cefotaxime exposure to the results of Gentamycin exposure. Result: There were 4 isolates of Escherichia coli which experienced changes in phenotype into Gentamycin resistant Escherichia coli. The rest of it still susceptible to Gentamycin on days 2, 4 and 10. Furthermore, the Escherichia coli isolates were both susceptible to Gentamycin and those that had phenotypic changes become resistant to Gentamycin after exposed to Cefotaxime as an ESBL screening. There are 8 (26.7%) isolates that are still susceptible to Cefotaxime and 18 (60%) isolates that have been transformed into ESBL-Gentamycin susceptible Escherichia coli. Isolates of 4 (13.3%) Gentamycin-resistant Escherichia coli are then exposed to Cefotaxime and obtained all isolates is resistant to Cefotaxime. Conclusion: Repeated exposure of Gentamycin for 14 days in vitro was not significantly related to the phenotypic changes of non ESBL-Gentamycin susceptible Escherichia coli isolates into ESBL-Gentamycin resistant Escherichia coli (P = 0.550, Phi=0.237).\n\n\n\nKeywords: Escherichia coli, Susceptible, Resistant, Gentamycin, ESBL\n\n\n","PeriodicalId":422504,"journal":{"name":"International Islamic Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Relationship Of Gentamycin Antibiotic Exposure To: Escherichia Coli Bacteria Resistant To Antibiotic Gentamycin And Escerichia Coli ESBL In Vitro\",\"authors\":\"D. Kusumawati\",\"doi\":\"10.33086/iimj.v3i1.2138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The development of bacteria that have been resistant to antibiotics can complicate the treatment process. Either causes of antibiotic resistance is inappropriate use of antibiotics. Gentamycin is an aminoglycoside-derived antibiotic which its role is very significant for gram-negative bacteria. Repeated use of gentamycin antibiotics can cause changes the effectiveness of gentamycin so that non ESBL-Gentamycin susceptible Escherichia Coli will change into ESBL-Gentamycin resistant Escherichia coli. Objective: This study aims to prove that repeated exposure to Gentamycin in vitro will change non ESBL-Gentamycin susceptible Escherichia Coli into ESBL Gentamycin resistant Escherichia Coli. Methods: This was an experimental study with 30 samples of non ESBL-Gentamycin susceptible Escherichia coli isolates identified from the Phoenix. Non ESBL- Gentamycin susceptible Escherichia coli was tested by giving exposure to Gentamycin for 14 days, then ESBL screening was tested by Cefotaxime exposure to the results of Gentamycin exposure. Result: There were 4 isolates of Escherichia coli which experienced changes in phenotype into Gentamycin resistant Escherichia coli. The rest of it still susceptible to Gentamycin on days 2, 4 and 10. Furthermore, the Escherichia coli isolates were both susceptible to Gentamycin and those that had phenotypic changes become resistant to Gentamycin after exposed to Cefotaxime as an ESBL screening. There are 8 (26.7%) isolates that are still susceptible to Cefotaxime and 18 (60%) isolates that have been transformed into ESBL-Gentamycin susceptible Escherichia coli. Isolates of 4 (13.3%) Gentamycin-resistant Escherichia coli are then exposed to Cefotaxime and obtained all isolates is resistant to Cefotaxime. Conclusion: Repeated exposure of Gentamycin for 14 days in vitro was not significantly related to the phenotypic changes of non ESBL-Gentamycin susceptible Escherichia coli isolates into ESBL-Gentamycin resistant Escherichia coli (P = 0.550, Phi=0.237).\\n\\n\\n\\nKeywords: Escherichia coli, Susceptible, Resistant, Gentamycin, ESBL\\n\\n\\n\",\"PeriodicalId\":422504,\"journal\":{\"name\":\"International Islamic Medical Journal\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Islamic Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33086/iimj.v3i1.2138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Islamic Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33086/iimj.v3i1.2138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:对抗生素具有耐药性的细菌的发展会使治疗过程复杂化。抗生素耐药性的任何一个原因都是抗生素的不当使用。庆大霉素是氨基糖苷类抗生素,对革兰氏阴性菌具有重要作用。反复使用庆大霉素类抗生素可引起庆大霉素有效性的改变,使非esbl -庆大霉素敏感大肠杆菌转变为esbl -庆大霉素耐药大肠杆菌。目的:本研究旨在证明体外反复暴露庆大霉素可使非ESBL-庆大霉素敏感大肠杆菌转变为ESBL-庆大霉素耐药大肠杆菌。方法:对从凤凰城中分离出的30株非esb -庆大霉素敏感大肠杆菌进行实验研究。对非ESBL-庆大霉素敏感的大肠杆菌进行庆大霉素暴露14天的检测,然后对庆大霉素暴露结果用头孢噻肟暴露进行ESBL筛选。结果:4株大肠埃希菌表型发生变化,转变为耐庆大霉素大肠埃希菌。其余的在第2、4和10天仍然对庆大霉素敏感。此外,大肠杆菌分离株对庆大霉素敏感,而那些有表型变化的大肠杆菌在暴露于头孢噻肟作为ESBL筛选后对庆大霉素产生耐药性。8株(26.7%)仍对头孢噻肟敏感,18株(60%)已转化为esbl -庆大霉素敏感大肠杆菌。然后将4株(13.3%)对庆大霉素耐药的大肠杆菌暴露于头孢噻肟,得到所有菌株对头孢噻肟耐药。结论:体外重复暴露庆大霉素14 d与非esbl -庆大霉素敏感大肠杆菌株向esbl -庆大霉素耐药大肠杆菌的表型变化无显著相关(P = 0.550, Phi=0.237)。关键词:大肠杆菌,敏感,耐药,庆大霉素,ESBL
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Relationship Of Gentamycin Antibiotic Exposure To: Escherichia Coli Bacteria Resistant To Antibiotic Gentamycin And Escerichia Coli ESBL In Vitro
Background: The development of bacteria that have been resistant to antibiotics can complicate the treatment process. Either causes of antibiotic resistance is inappropriate use of antibiotics. Gentamycin is an aminoglycoside-derived antibiotic which its role is very significant for gram-negative bacteria. Repeated use of gentamycin antibiotics can cause changes the effectiveness of gentamycin so that non ESBL-Gentamycin susceptible Escherichia Coli will change into ESBL-Gentamycin resistant Escherichia coli. Objective: This study aims to prove that repeated exposure to Gentamycin in vitro will change non ESBL-Gentamycin susceptible Escherichia Coli into ESBL Gentamycin resistant Escherichia Coli. Methods: This was an experimental study with 30 samples of non ESBL-Gentamycin susceptible Escherichia coli isolates identified from the Phoenix. Non ESBL- Gentamycin susceptible Escherichia coli was tested by giving exposure to Gentamycin for 14 days, then ESBL screening was tested by Cefotaxime exposure to the results of Gentamycin exposure. Result: There were 4 isolates of Escherichia coli which experienced changes in phenotype into Gentamycin resistant Escherichia coli. The rest of it still susceptible to Gentamycin on days 2, 4 and 10. Furthermore, the Escherichia coli isolates were both susceptible to Gentamycin and those that had phenotypic changes become resistant to Gentamycin after exposed to Cefotaxime as an ESBL screening. There are 8 (26.7%) isolates that are still susceptible to Cefotaxime and 18 (60%) isolates that have been transformed into ESBL-Gentamycin susceptible Escherichia coli. Isolates of 4 (13.3%) Gentamycin-resistant Escherichia coli are then exposed to Cefotaxime and obtained all isolates is resistant to Cefotaxime. Conclusion: Repeated exposure of Gentamycin for 14 days in vitro was not significantly related to the phenotypic changes of non ESBL-Gentamycin susceptible Escherichia coli isolates into ESBL-Gentamycin resistant Escherichia coli (P = 0.550, Phi=0.237). Keywords: Escherichia coli, Susceptible, Resistant, Gentamycin, ESBL
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Consanguinity via Breastfeeding in view of Islam and Science of Epigenetics Treatment Problems In Triple Negative Breast Cancer Epidemiological Review: Mapping Cases and Prevalence of Helminthiasis in Indonesia on 2020-2022 Effect of Honey Administration on The Histopathology of The Duodenum of Wistar Rats as a Inhibition of The Toxic Effects of Borax (Sodium tetraborate) Proximate and Some Micronutrients (Zn, Se, Fe and I) Assessed in Goat Milk, and Cattle Milk in Sokoto, Nigeria
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1